4Q sales, trends for key Bristol-Myers medicines

AP News
|
Posted: Jan 26, 2012 2:26 PM
4Q sales, trends for key Bristol-Myers medicines

Global sales of key Bristol-Myers Squibb drugs in 2011's fourth quarter:

Drug name Use 2011 Change from 2010

Plavix Blood thinner $1.67 billion Down 3 percent

Abilify Psychiatric disorders $737 million Up 4 percent

Reyataz HIV/AIDS $416 million Up 11 percent

Sustiva HIV/AIDS $412 million Up 14 percent

Baraclude Hepatitis B $318 million Up 20 percent

Orencia Rheumatoid arthritis $257 million Up 27 percent

Sprycel Leukemia $227 million Up 34 percent

Avapro/Avalide High blood pressure $195 million Down 23 percent

Onglyza Type 2 diabetes $153 million Up 110 percent

Yervoy Melanoma $144 million N.A. (new drug)

___

Source: Bristol-Myers Squibb Co.